NasdaqGS:IRTCMedical Equipment
Did iRhythm's (IRTC) Upgraded 2025–2026 Revenue Outlook Just Shift Its Investment Narrative?
In January 2026, iRhythm Technologies raised its full-year 2025 revenue guidance to exceed the prior October range and issued new 2026 revenue guidance of about US$870 million to US$880 million, implying roughly 17% to 18% year-over-year growth.
The company attributed this upgraded outlook to record fourth-quarter 2025 revenue unit volume, pointing to strong demand for its cardiac monitoring services and devices.
Next, we will examine how iRhythm’s upgraded 2025 guidance and double-digit...